 article offers  outlines   brazilian biotechnology  human health sector,  terms  scientific output, dependence   private sector  public funding  ,   capacity  innovation   development   pharmaceuticals   uncoupling  progresses  science  technology  innovation   private sector  biotechnology  human health, showing  spatial  sectoral concentration.    relevant aspects - territorial distribution, scientific output    private corporations -,   ,   progresses   sector,    weaknesses  overcome  order  promote economic growth based  knowledge  innovation.